Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    May 2022
  1. ABDELNABI M, Elmssary M, Sekhon J, Benjanuwattra J, et al
    Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive Monospot test in a patient on lamotrigine: DRESS syndrome.
    Lancet. 2022;399:1902.
    PubMed    


    April 2022
  2. LOMMATZSCH M, Brusselle GG, Canonica GW, Jackson DJ, et al
    Disease-modifying anti-asthmatic drugs.
    Lancet. 2022;399:1664-1668.
    PubMed    


    March 2022
  3. CRAIG T, Magerl M, Levy DS, Reshef A, et al
    Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2022;399:945-955.
    PubMed     Abstract available


  4. FIJEN LM, Levi M
    Prophylaxis with anti-activated factor XII for hereditary angioedema.
    Lancet. 2022;399:889-890.
    PubMed    


    January 2022
  5. JONES SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, et al
    Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
    Lancet. 2022;399:359-371.
    PubMed     Abstract available


  6. GREENHAWT M, Shaker M, Abrams EM
    Peanut oral immunotherapy in very young children.
    Lancet. 2022;399:336-337.
    PubMed    


    October 2021
  7. ASHER MI, Rutter CE, Bissell K, Chiang CY, et al
    Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study.
    Lancet. 2021;398:1569-1580.
    PubMed     Abstract available


  8. PIJNENBURG MW, Nantanda R
    Rising and falling prevalence of asthma symptoms.
    Lancet. 2021;398:1542-1543.
    PubMed    


  9. JANKAUSKAITE L, Oostenbrink R
    Childhood lower respiratory tract infections: more evidence to do less.
    Lancet. 2021;398:1383-1384.
    PubMed    


  10. BUSH A, Pavord ID
    Forthcoming UK asthma guidelines: an opportunity to improve asthma outcomes.
    Lancet. 2021 Oct 14. pii: S0140-6736(21)02244.
    PubMed    


    August 2021
  11. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    PubMed     Abstract available


  12. DEHGHAN N, Marcon KM, Sedlic T, Beck DB, et al
    Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum.
    Lancet. 2021;398:621.
    PubMed    


    May 2021
  13. FITZCHARLES MA, Cohen SP, Clauw DJ, Littlejohn G, et al
    Nociplastic pain: towards an understanding of prevalent pain conditions.
    Lancet. 2021;397:2098-2110.
    PubMed     Abstract available


  14. REICH K, Teixeira HD, de Bruin-Weller M, Bieber T, et al
    Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2021 May 20. pii: S0140-6736(21)00589.
    PubMed     Abstract available


  15. GUTTMAN-YASSKY E, Teixeira HD, Simpson EL, Papp KA, et al
    Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
    Lancet. 2021 May 20. pii: S0140-6736(21)00588.
    PubMed     Abstract available


  16. THYSSEN JP, Thomsen SF
    Treatment of atopic dermatitis with biologics and Janus kinase inhibitors.
    Lancet. 2021 May 20. pii: S0140-6736(21)00717.
    PubMed    


    January 2021
  17. SIMPSON EL, Bieber T, Thyssen JP, Valdez H, et al
    Abrocitinib for atopic dermatitis - Authors' reply.
    Lancet. 2021;397:196.
    PubMed    


  18. UPPAL SK, Chat VS, Kearns DG, Wu JJ, et al
    Abrocitinib for atopic dermatitis.
    Lancet. 2021;397:195-196.
    PubMed    


    September 2020
  19. VON MUTIUS E, Smits HH
    Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention.
    Lancet. 2020 Sep 7. pii: S0140-6736(20)31861.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: